Cargando…
A Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature
A 15-year-old girl with maternal inheritance of neurofibromatosis type 1 (NF1) and paternal inheritance of tuberous sclerosis complex (TSC) developed intractable epilepsy at age 5. Her seizures were refractory to adequate doses of four antiepileptic medications until felbamate was initiated at age 7...
Autores principales: | Mishal, Natanya M., Arkilo, Dimitrios, Tang, Ju, Crawford, John R., Wang, Sonya G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633543/ https://www.ncbi.nlm.nih.gov/pubmed/26579319 http://dx.doi.org/10.1155/2015/960746 |
Ejemplares similares
-
Felbamate for pediatric epilepsy—should we keep on using it as the last resort?
por: Rabinowicz, Shira, et al.
Publicado: (2022) -
Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy
por: Dewey, Curtis Wells, et al.
Publicado: (2022) -
Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex
por: Yang, Jian, et al.
Publicado: (2007) -
Epilepsy and TSC-Associated Neuropsychiatric Disorders
por: Capal, Jamie K.
Publicado: (2020) -
Correlation between TSC1 gene polymorphism and epilepsy
por: Jiang, Xiuli, et al.
Publicado: (2017)